Beaumont Capital Management, LLC Caribou Biosciences, Inc. Transaction History
Beaumont Capital Management, LLC
- $136 Million
- Q3 2024
A detailed history of Beaumont Capital Management, LLC transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Beaumont Capital Management, LLC holds 16,320 shares of CRBU stock, worth $23,337. This represents 0.02% of its overall portfolio holdings.
Number of Shares
16,320Holding current value
$23,337% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding CRBU
# of Institutions
134Shares Held
52.6MCall Options Held
148KPut Options Held
70.7K-
Black Rock Inc. New York, NY6.95MShares$9.94 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.62MShares$6.6 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC4.57MShares$6.54 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA4.31MShares$6.16 Million0.49% of portfolio
-
Kynam Capital Management, LP Princeton, NJ2.36MShares$3.37 Million0.38% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $87M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...